Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Tokyo Kiraboshi Financial, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 13%, Oct-Dec Ordinary Profit Increases by 31%
7173 Tokyo Kiraboshi Financial Group,Inc. 【J-GAAP】
Earnings ReportTokyo Kiraboshi Financial Group,Inc. <7173> [TSE Prime] announced its financial results after the market closed on January 31st (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) increased 12.8% from the same period last year, reaching 30.5 billion yen. The progress rate toward the full-year plan of 32.1 billion yen was 95.1%, also surpassing the five-year average of 86.0%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to significant drop 73.2% from the same period last year to 1.58 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit increased 31.4% from the same period last year, reaching 11.4 billion yen.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 89,930 | ー | 20,325 | 13,596 | 446.5 | 66.0 | Feb 1, 2023 | J-GAAP |
Apr - Dec, 2023 | 102,819 | ー | 27,044 | 18,644 | 612.8 | 82.0 | Jan 31, 2024 | J-GAAP |
Apr - Dec, 2024 | 117,016 | ー | 30,512 | 20,777 | 682.8 | 95.1 | Jan 31, 2025 | J-GAAP |
YoY | +13.8% | - | +12.8% | +11.4% | +11.4% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 68,363 | ー | 14,659 | 12,179 | 398.6 | 80 | May 1, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | ー | ー | 13,066 | 11,581 | 378.0 | 75 | Nov 1, 2024 | J-GAAP |
YoY | - | - | -10.9% | -4.9% | -5.2% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 125,291 | ー | 30,774 | 21,150 | 693.0 | 115 | May 8, 2023 | J-GAAP |
Mar, 2024 | 138,331 | ー | 32,968 | 25,652 | 839.6 | 145 | May 1, 2024 | J-GAAP |
Mar, 2025 Guidance | ー | ー | 32,100 | 24,500 | 799.6 | 150 | May 1, 2024 | J-GAAP |
YoY | - | - | -2.6% | -4.5% | -4.8% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 32,851 | ー | 8,735 | 5,171 | 170.0 | 0.0 | Jan 31, 2024 | J-GAAP |
Jan - Mar, 2024 | 35,512 | ー | 5,924 | 7,008 | 229.4 | 0.0 | May 1, 2024 | J-GAAP |
Apr - Jun, 2024 | 38,841 | ー | 9,657 | 6,511 | 215.7 | 0.0 | Jul 29, 2024 | J-GAAP |
Jul - Sep, 2024 | 38,113 | ー | 9,377 | 6,408 | 209.7 | 0.0 | Nov 1, 2024 | J-GAAP |
Oct - Dec, 2024 | 40,062 | ー | 11,478 | 7,858 | 258.3 | 0.0 | Jan 31, 2025 | J-GAAP |
YoY | +22.0% | - | +31.4% | +52.0% | +51.9% |
Related Articles
Kawagishi Bridge Works, Oct-Dec (1Q) Ordinary Profit Decreases by 13%
WELLNET, First Half Ordinary Profit Increases by 45%, Oct-Dec Ordinary Profit Increases by 29%
TOHO SYSTEM SCIENCE, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 6%
Temairazu, First Half Ordinary Profit Increases by 9%, Oct-Dec Ordinary Profit Increases by 11%
KUNIMINE INDUSTRIES, Oct-Dec (3Q) Ordinary Profit Increases by 24%
MEIDENSHA, The Current Fiscal Year Ordinary Profit Revised Upward by 19%, Raises Record High Profit Forecast
Sumitomo Pharma, The Current Fiscal Year Net Income Turns to Profit, Exceeds Expectations
TDSE, The Current Fiscal Year Ordinary Profit Revised Upward by 35%
NSK, Apr-Dec (Cumulative 3Q) Net Income Decreases by 17%, Oct-Dec Net Income Decreases by 52%
ZEON, The Current Fiscal Year Ordinary Profit Revised Upward to an Unexpected 11% Increase